Mereo Biopharma Group Plc ADR (MREO) concluded trading on Wednesday at a closing price of $3.36, with 6.62 million shares of worth about $22.24 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 189.66% during that period and On Wednesday, January 24 the price saw a gain of about 12.37%. Currently the company’s common shares owned by public are about 128.39M shares, out of which, 128.39M shares are available for trading.
abrdn Healthcare Investors, abrdn Life Sciences Investors, and Formidable ETF are the top 3 mutual funds which are holding stakes in Mereo Biopharma Group Plc ADR abrdn Healthcare Investors is currently holding 1.06 million shares of worth totaling $2.46 million. The company recently came buying 0.0 shares which brought its stake up to 0.76% of the company’s outstanding shares. Formidable ETF, after buying 0.32 million shares, have now control over 0.23% of the stake in the company. It holds 0.0 shares of worth $0.74 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the stock later moved at a day high price of 3.4150, or with a gain of 12.37%. Stock saw a price change of 6.84% in past 5 days and over the past one month there was a price change of 63.90%. Year-to-date (YTD), MREO shares are showing a performance of 45.45% which increased to 229.41% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.69 but also hit the highest price of $3.35 during that period. The average intraday trading volume for Mereo Biopharma Group Plc ADR shares is 1.13 million. The stock is currently trading 26.04% above its 20-day simple moving average (SMA20), while that difference is up 45.39% for SMA50 and it goes to 113.09% higher than SMA200.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) currently have 128.39M outstanding shares and institutions hold larger chunk of about 56.48% of that. Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.
The stock has a current market capitalization of $431.39M and its 3Y-monthly beta is at 0.82. It has posted earnings per share of -$0.25 in the same period. It has Quick Ratio of 3.11 while making debt-to-equity ratio of 0.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MREO, volatility over the week remained 13.45% while standing at 9.80% over the month.
Analysts are in expectations that Mereo Biopharma Group Plc ADR (MREO) stock would likely to be making an EPS of $Mereo BioPharma Group plc in the current quarter, while forecast for next quarter EPS is $3.36 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $INSTITUTE BIOMEDICAL RESH CORP which is $MARGO CARIBE INC at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $MREE in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 34.59% while it is estimated to increase by 100.67% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on October 13, 2023 offering a Buy rating for the stock and assigned a target price of $4 to it.
